Matthew Carnevale

Title: The Innovative Contributions of Matthew Carnevale

Introduction

Matthew Carnevale is a notable inventor based in Montréal, Canada. He has made significant strides in the field of bionanotechnology, particularly with his innovative patent that focuses on the development of a bionanofluid. His work has implications for various applications, including imaging and therapeutic agents.

Latest Patents

Matthew Carnevale holds a patent for a bionanofluid designed for use as a contrast, imaging, disinfecting, and/or therapeutic agent. This bionanofluid comprises a carbon-based nanomaterial that is substantially mono-dispersed in a fluid. The carbon-based nanomaterial is surface modified with a polar group when the fluid is polar or with a non-polar group when the fluid is non-polar. It is also functionalized with a biological targeting moiety to facilitate specific association with targeted entities. Furthermore, a hybrid bionanofluid includes the bionanofluid, with the carbon-based nanomaterial further modified with a hybrid nanoparticle that may consist of an alloy, transition metal, semi-conductor, semi-metal, or polymer-based nanoparticle with a biological targeting moiety. This innovative solution is useful in multimodal imaging techniques such as photo-luminescence, luminescence, photo-acoustic imaging, MRI, and ultrasound, as well as in cellular targeting.

Career Highlights

Matthew Carnevale is affiliated with the Royal Institution for the Advancement of Learning/McGill University, where he contributes to research and development in his field. His work is characterized by a commitment to advancing the understanding and application of nanotechnology in medicine and imaging.

Collaborations

Matthew has collaborated with notable colleagues, including Mark Trifiro and Miltiadis Paliouras, who share his passion for innovation and research in bionanotechnology.

Conclusion

Matthew Carnevale's contributions to the field of bionanotechnology exemplify the potential of innovative solutions in medical applications. His patent for a bionanofluid represents a significant advancement in imaging and therapeutic technologies.